雾化myo-inositol增加了支气管切除症患者的粘液清除:一个回顾性研究
1Systems Biology Group Lab, Sapienza University, Rome, Italy. mariano.bizzarri@uniroma1.it.
European review for medical and pharmacological sciences
|July 31, 2023
概括
雾化的myo-inositol显著改善了支气管切除症患者的肺功能和粘液清除. 这种处理可以减少吐液的固体含量和表面活性剂的张力,从而改善呼吸系统的健康.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 支气管切开症是一种慢性呼吸道疾病,其特征是不可逆转的气道扩张.
- 支气管切除症的有效管理策略侧重于改善粘液清除和肺功能.
- 伊诺西托是天然存在的化合物,具有潜在的治疗应用.
研究的目的:
- 评估 nebulized myo-inositol 在治疗支气管病的临床效用.
- 评估myo-inositol对肺功能和唾液特性的影响.
主要方法:
- 这是一项追溯性研究,涉及19名支气管切除症患者 (年龄为63-73岁).
- 患者在15天内接受了 nebulized myo-inositol 或安慰剂.
- 分析的关键参数包括肺功能 (FEV1,FEF25-75%),排泄物固体含量和表面活性剂张力.
主要成果:
- 雾化myo-inositol显著降低吐液固体含量 (p<0.001) 和表面活性剂张力 (p<0.001).
- 这些参数的改善与改善的肺功能得分相关 (FEV1和FEF25-75%).
- 表面活性剂张力变化与FEV1得分有显著的相关性 (p<0.05).
结论:
- 雾化myo-inositol在改善支气管炎的粘液清除方面表现出有效性.
- 治疗对患有这种疾病的患者的肺功能产生了积极的影响.
- 肌肉中毒醇代表了支气管切除症管理的有前途的治疗选择.
相关概念视频
Drugs Used in Upper Respiratory Disorders: Overview
291
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
291
Inhaled Medications
311
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
311
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
300
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
300
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K


